Satellite Symposia

Learn about new products, disease states and earn additional CME at Hospital Medicine 2019.

Sunday, March 24, 2019

5:30 – 7:30 p.m.

Gaylord National Resort and Convention Center – National Harbor 4-5

Hepatology News Tonight: Managing Complications of Cirrhosis

Registration starts at 5:30 p.m.

CME Dinner Symposium 6:00 – 7:30 p.m.

Target Audience:

This activity has been designed to meet the educational needs of physicians, advanced practice providers and allied health professionals who provide care for hospitalized patients with liver disease.

Learning Objectives:

After completing this program, participants should be better able to:

  • Understand the complications and the consequences of cirrhosis.
  • Describe the economic, patient and caregiver burdens associated with cirrhosis.
  • Demonstrate the ability to properly treat the complications of cirrhosis and prevent recurrence.

Faculty:

Robert S. Brown, Jr., MD, MPH (Chair)

Gladys and Roland Harriman Professor of Medicine
Vice Chair for Mentorship and Academic Development
Clinical Chief, Division of Gastroenterology & Hepatology
Weill Cornell Medicine
New York, New York

Kimberly Brown, MD, FAST, FAASLD, AGAF

Professor of Medicine Wayne State University
Chief, Gastroenterology and Hepatology
Associate Medical Director, Henry Ford Hospital Transplant Institute
Henry Ford Hospital
Detroit, Michigan

Steven Flamm, MD, FAASLD, FACG

Chief, Liver Transplantation Program,
Professor of Medicine and Surgery
Northwestern Feinberg School of Medicine
Chicago, Illinois

Accredited by:

Rehoboth McKinley Christian Health Care Services

Provided by:

CLDF (Chronic Liver Disease Foundation)
Supported by an educational grants from Mallinckrodt and Salix Pharmaceuticals.

Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the New Mexico Medical Society (NMMS) through the joint providership of Rehoboth McKinley Christian Health Care Services (RMCHCS), the Chronic Liver Disease Foundation (CLDF), and the Texas Gulf Coast Gastroenterological Society (TGCGS). RMCHCS is accredited by the NMMS to provide continuing medical education for physicians.

RMCHCS designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Americans with Disabilities Act: The event staff will be glad to assist you with any special needs (i.e., physical dietary, etc.).

Held in Conjunction with Hospital Medicine 2019, SHM’s Annual Conference.

For more information click here.

On-site registration is available.

Space is limited, so please arrive by 5:00 p.m.
Seating is on a first-come, first served-basis.

Sunday, March 24, 2019

5:30 – 7:30 p.m.

Gaylord National Resort and Convention Center – Woodrow Wilson BC

An Evidence-Based Approach to Reducing Stroke Risk in Nonvalvular Atrial Fibrillation
Program

Description:

This lecture will present options for reducing the risk of stroke in patients with nonvalvular atrial fibrillation.

Faculty:

Dharmesh Patel, MD MBBS (London) FACC FACP FASPC FNLA

Stern Cardiovascular Foundation
President of AfPA (Alliance for Patient Access)
Past American Heart Association President
Past Chairman of Medicine Baptist Desoto Hospital
Board of AHA Southeast America
Memphis, Tennessee

Sponsored by Janssen Pharmaceuticals Inc.

Monday, March 25, 2019

12:00 – 1:00 p.m.

Gaylord National Resort and Convention Center – National Harbor 2-3

Lunch provided beginning at Noon

Understanding Your Legal Tools: The Key’s to Lawsuit Prevention, License Protection and Tax Reduction

Objectives:

  • Learn how to protect your license from negative reports to the NPDB following a settlement from your insurance company. If there is no NPD report, it’s unlikely that a board investigation into legal matters will materialize, preventing any sanctions from the state licensing board.
  • Learn the best business structure for income tax reduction. Learn about the new tax laws passed in 2018 and how they can benefit you.
  • Learn the use of legal tools that will protect your professional and personal assets from lawsuits. (Statistically, not even one in 100,000 are using these tools in the right way.)
  • Learn how to protect business, property and personal assets in the event of a judgment in excess of liability insurance.
  • Shows how to structure: C-corps, S-corps, FLP’s, LLC’s, etc.

Faculty:

Art McOmber

Sponsored by Legally Mine

Monday, March 25, 2019

7:00 – 9:30 p.m.

Gaylord National Resort and Convention Center – Cherry Blossom Ballroom

Dinner provided beginning at 7:00 p.m.

Evidence-Based Approach to COPD Management: Exploring New Guidelines and Treatment Options for Managing COPD Exacerbations

Learning Objectives:

After completing this program, participants should be better able to:

  • Discuss considerations for reducing the risk of exacerbations in the inpatient and ambulatory setting.
  • Raise awareness of strategies to improve COPD standardization of care across sites of care.
  • Evaluate the role of long-acting bronchodilators to treat underlying pathophysiology of exacerbations.
  • Understand the importance of inhaler selection when initiating maintenance therapy or reassessing treatment based on disease progression.

Faculty:

Roy A. Pleasants, PharmD, BCPS

Duke University School of Medicine

Haley M. Hoy, PhD, ACNP, FAANP

The University of Alabama Huntsville
Vanderbilt Medical Center

Sponsored by Boehringer Ingelheim

Monday, March 25, 2019

7:00 – 9:00 p.m.

Gaylord National Resort and Convention Center – National Harbor 2-3

Dinner provided beginning at 7:00 p.m.

C. difficile Infection: A Hospitalist’s Roadmap to Treatment and Prevention of Recurrence

Program Overview:

Clostridium difficile infection (CDI) places a significant clinical and economic burden on the healthcare system. The rising incidence of CDI is attributed to the emergence of a previously rare and hypervirulent strain of C. difficile. Increased toxin production and high-level antimicrobial resistance have allowed this strain to thrive in healthcare settings. Furthermore, populations previously thought to be at low risk of infection are now being identified as having severe CDI, including those without any exposure to healthcare facilities. Fortunately, new diagnostic techniques have been developed to assist clinicians in the accurate and rapid detection of these infections. Additionally, new treatment options are available to clinicians for the management of initial and recurrent episodes of CDI. The prevention and management of CDI involves multiple disciplines responsible for the care of at-risk patients. As a key patient advocate in the hospital, the hospitalist can play a major role in ensuring that appropriate measures are in place for their patients at high risk for CDI. Hospitalists can also ensure that timely and appropriate diagnostic tests are performed at the early signs of CDI and appropriate treatment selection is based on patient factors.

Faculty:

William Ford, MD, SFHM

Regional Director Hospital Medicine
Clinical Associate Professor of Medicine
Abbington Jefferson Health
Abbington, PA

Jason C. Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS

Clinical Professor
Clinical Specialist, Infectious Diseases
Director, PGY2 Residency in Infectious Diseases Pharmacy
Temple University
Philadelphia, PA

Ciaran P. Kelly, MD

Professor of Medicine
Harvard Medical School
Director Gastroenterology Fellowship Training
Director Celiac Center
Beth Israel Deaconess Medical Center
Boston, MA

Registration: http://www.vemcomeded.com/livemeetings.asp or call 908-704-2400

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Center for Independent Healthcare Education (Center) and Vemco MedEd. Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Center designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Supported by an educational grant from Merck & Co., Inc.

Jointly provided by Center for Independent Healthcare Education and Vemco MedEd.